What's in Mimetogen Pharmaceuticals USA, Inc.'s pipeline?

Mimetogen Pharmaceuticals USA, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mimetogen Pharmaceuticals USA, Inc.'s portfolio?

Top competitors by shared drug class: Ahn-Gook Pharmaceuticals Co.,Ltd, Avalo Therapeutics, Inc., Chang Gung Memorial Hospital, ChemRar Research and Development Institute, LLC, Chia Tai Tianqing Pharmaceutical Group Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mimetogen-pharmaceuticals-usa-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Mimetogen Pharmaceuticals USA, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mimetogen Pharmaceuticals USA, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
MIM-D3 Ophthalmic Solution	MIM-D3 Ophthalmic Solution	phase 3	small molecule	GRK1	Ophthalmology
Tavilermide ophthalmic solution	Tavilermide ophthalmic solution	phase 3	Integrin antagonist	Integrins (α4β1, αLβ2, and other integrin subtypes)	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Avalo Therapeutics, Inc. · 1 shared drug class
Chang Gung Memorial Hospital · 1 shared drug class
ChemRar Research and Development Institute, LLC · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
Cipla BioTec Pvt. Ltd. · 1 shared drug class
Daewon Pharmaceutical Co., Ltd. · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mimetogen Pharmaceuticals USA, Inc.:

Cite this brief

Drug Landscape (2026). Mimetogen Pharmaceuticals USA, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mimetogen-pharmaceuticals-usa-inc. Accessed 2026-05-17.